Director Robert Ferrara resigns; David Deming appointed Lead Independent Director

Phio Pharmaceuticals Corp.

Robert Ferrara resigned effective Oct 31, 2025; no disagreement cited.
Board reduced from 6 to 5 members; no vacancies remain.
David Deming appointed Lead Independent Director; brings 30+ yrs investment banking (JP Morgan).
Deming joined Phio Board in Feb 2025; serves on Nominating Committee.

item 5.02item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.